416‑304‑9935

NEWS RELEASES

Matica To Launch CBD Infused Topicals

March 12, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (MQPXF – OTCQB) (39N – Frankfurt) (“Matica” or the “Company”) is pleased to report that Yunify Natural Technologies and its research affiliates (“Yunify”)are nearing completion of the research for...

read more

Matica To Begin Trading On The OTCQB

March 5, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (MQPXF – OTCQB) (39N – Frankfurt) (“Matica” or the “Company”) is pleased to announce it has been approved to begin trading on the OTCQB tomorrow under the symbol "MQPXF". Real-time information,...

read more

Dorval Receives Second Shipment Of Clones – Revised

February 21, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is pleased to announce that the Dorval growing facility has received its second shipment of rooted starting materials. 500 clones of...

read more

Matica and Yunify Develop First New Consumer Product

November 6, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to announce that Yunify Natural Technologies (“Yunify”) and Matica have developed our first unique and proprietary...

read more

Matica Receives Cultivation Licence for Dorval Facility

October 15, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to announce that RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has been granted a license to cultivate cannabis under...

read more

Matica Files Q1 Financials And Management Discussion

May 30, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is very pleased to announce that the Company has SEDAR filed the unaudited Financial Statements and corresponding Management Discussion...

read more

Matica Reports on Recent Market Activity

November 21, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) at the request of the Investment Industry Regulatory Organization of Canada, management is pleased to provide an update on Company...

read more

Update on U.S. Cannabis Exposure

Dear Shareholders Recently the Canadian Securities Administrators (“CSA”) have issued a staff notice regarding Canadian issuers that have, or are currently in the process of developing, exposure to cannabis-related activities in U.S. states that have legalized such...

read more

Matica Retains Mr. Peter Duffus as Consultant

October 4, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to announce that the company has retained the services of Mr. Peter Duffus as a consultant to the company. Mr. Duffus is...

read more

Matica Completes Review of Second ACMPR Application

September 8, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to report that the Company has completed its due diligence on the second application under the Access To Cannabis for...

read more

Matica Reports on Site Inspection of Dorval Facility

August 25, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to report that Company management has completed a site visit at the Dorval, Quebec medical marijuana facility. ...

read more